Eidam Diagnostics Corporation
announces Dr. Michael Kalden, M.D. as Chief Scientific Officer
Richmond, BC – January 5, 2007
Eidam Diagnostics Corporation is pleased to announce that Dr.
Michael Kalden, M.D. has been appointed as the Company’s Chief
Scientific Officer, effective January 4, 2007. Dr. Kalden is a
specialist in the field of oncology and holistic cancer therapy
and has held numerous appointments with leading medical
institutions in Germany. Dr. Kalden has used the CRT 2000®
Thermographic System as a core part of his cancer detection and
treatment monitoring protocol for over 10 years. His areas
of expertise also include naturopathy and pain control.
Dr. Kalden is presently the head physician and medical director
for the Veramed Hospital at Tannenberg Hospital, in which he
specializes in holistic cancer therapy. He has held this
position since 1989. In addition, he has been the co-founder of
the Society of Biological Medicine, Inc. in Berlin-Mesched and
has headed studies in the Mibeg Institute in Cologne, Germany.
Recently, Dr. Kalden has opened a new private surgery for
oncology and naturopathy in the Dortmund center for hyperthermia
and continues his co-operation with the Panacea Center for
Preventative Medicine and Research in Vancouver, B.C., Canada.
Bernard Armani, CEO of Eidam Diagnostics, states, “We have
always valued Dr. Kalden's support and generous contributions to
the development of the CRT 2000®. It is now with great pleasure
that we welcome Dr. Kalden's direct involvement as a member of
the Eidam Team and we look forward to the ultimate benefit from
his knowledge, guidance and expertise. Dr. Kalden will play a
key role in both scientific and corporate growth of Eidam
Eidam Diagnostics Corporation is a privately held Canadian
company headquartered in Richmond, British Columbia, with
offices in German and China.
The company's primary product, the CRT 2000® Thermographic
System is intended for use in preventative healthcare, and is
able to detect the changes in the body's temperature regulation
to produce data that can be used for adjunctive diagnosis of
The CRT 2000® is the only contact thermography device of its
kind in the world. It is non-invasive, emits no radiation, and
can be used repeatedly for treatment monitoring.
The CRT 2000® has obtained CE accreditation and has been
listed as a US FDA 510(k) Class I medical
Eidam aims to prevent the progression of disease, by identifying
the initial development of illnesses before symptoms manifest.
For more information about Eidam Diagnostics Corporation, please
contact Shelley Leonhardt, Senior Vice President, at (604)
304-6016 or visit our website at www.eidam.com.
Return to Press Releases